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Abstract
Pyrabactin, a synthetic agonist of abscisic acid (ABA), inhibits seed germination and hypocotyl growth and
stimulates gene expression in a very similar way to ABA, implying the possible modulation of stomatal function by
pyrabactin as well. The effect of pyrabactin on stomatal closure and secondary messengers was therefore studied in
guard cells of Pisum sativum abaxial epidermis. Pyrabactin caused marked stomatal closure in a pattern similar to
ABA. In addition, pyrabactin elevated the levels of reactive oxygen species (ROS), nitric oxide (NO), and cytoplasmic
pH levels in guard cells, as indicated by the respective ﬂuorophores. However, apyrabactin, an inactive analogue of
ABA, did not affect either stomatal closure or the signalling components of guard cells. The effects of pyrabactin-
induced changes were reversed by pharmalogical compounds that modulate ROS, NO or cytoplasmic pH levels,
quite similar to ABA effects. Fusicoccin, a fungal toxin, could reverse the stomatal closure caused by pyrabactin, as
well as that caused by ABA. Experiments on stomatal closure by varying concentrations of ABA, in the presence of
ﬁxed concentration of pyrabactin, and vice versa, revealed that the actions of ABA and pyrabactin were additive.
Further kinetic analysis of data revealed that the apparent KD of ABA was increased almost 4-fold in the presence of
ABA, suggesting that pyrabactin and ABA were competing with each other either at the same site or close to the
active site. It is proposed that pyrabactin could be used to examine the ABA-related signal-transduction
components in stomatal guard cells as well as in other plant tissues. It is also suggested that pyrabactin can be
used as an antitranspirant or as a priming agent for improving the drought tolerance of crop plants.
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Introduction
Stomatal closure is an adaptation to conserve water loss
during drought/water stress conditions. During the stress
conditions, the synthesis and mobilization of abscisic acid
(ABA) form key physiological events, facilitating stomatal
closure by ABA (Seo and Koshiba, 2002; Christmann et al.,
2006). In view of the powerful effects of ABA, the signalling
components during ABA-induced stomatal closure have
been examined extensively (Hetherington, 2001; Wasilewska
et al., 2008; Acharya and Assmann, 2009; Kim et al., 2010).
Protein phosphatases such as ABI1, ABI2, and HAB1 are
negative regulators during ABA-induced stomatal closure,
while protein kinases such as SnRK2s (including OST1) are
positive regulators (Mustilli et al., 2002; Li et al., 2006;
Hubbard et al., 2010; Kim et al., 2010). Other protein
kinases such as CBLs and CIPKs also play crucial roles in
ABA-induced stomatal closure. In addition, ABA promotes
the activity of anion channels (e.g. SLAK1, AtALMT12)
and down-regulates the activity of inward K
+ channels
(KAT1and KAT2) in stomatal guard cells (Geiger et al.,
2009; Lee et al., 2009; Sirichandra et al., 2009; Kim et al.,
2010). Besides the above signalling components, participa-
tion of several small molecules like reactive oxygen species
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2+, besides a rise
in guard cell pH are all essential during ABA-mediated
stomatal closure (Neill et al., 2002; Suhita et al., 2004;
Gonugunta et al., 2008, 2009).
Despite repeated attempts, the identity of ABA putative
receptors was not established for a long time. In 2009, two
independent groups identiﬁed and established that PYR/
PYL/RCAR proteins, that belong to the cyclase subfamily
of the START/Bet v I protein superfamily, acted as ABA
receptors in Arabidopsis (Ma et al., 2009; Park et al., 2009).
Soon after, the crystallization, molecular modelling, and
simulation of the structure of PYR/PYL/RCAR proteins
unravelled the novel mechanisms of their function
(Nishimura et al., 2009; Yin et al., 2009; Melcher et al.,
2010a). In the absence of ABA, PP2Cs keep the pool of
SnRK2s dephosphorylated and limit the phosphorylation of
transcription factors involved in ABA-induced gene expres-
sion. When present, ABA binds to PYR/PYL and then to
PP2C making a functional complex, and blocks the normal
function of PP2C. As a result, the SnRK2s stay in
a phosphorylated state and activate the transcription factors
and induce ABA-activated gene expression (Cutler et al.,
2010; Melcher et al., 2010b; Raghavendra et al., 2010).
The identiﬁcation of PYR/PYL proteins as ABA recep-
tors was made possible by the discovery of pyrabactin
(4-bromo-N-(pyridine-2-yl methyl) naphthalene-1-sulfon-
amide), a synthetic compound. Pyrabactin was found to
suppress markedly seed germination and hypocotyl growth,
besides the promotion of gene expression, very similar to
the pattern with ABA (Park et al., 2009). Pyrabactin was
considered as a potential anti-transpirant/stress adaptor,
with possible uses in agriculture. It became clear that
pyrabactin was acting as an agonist during ABA action.
The expression of pyr/pyl mRNA was quite high not only in
the seeds, but also in guard cells. In addition, the
Arabidopsis quadruple mutants lacking pyr1pyl1pyl2pyl4
were impaired in ABA-induced stomatal closure and the
ABA-inhibition of stomatal opening (Nishimura et al.,
2010). All these studies imply that pyrabactin must affect
guard cell function and stomatal closure. However, there
have been no direct detailed experiments on stomatal
closure in response to pyrabactin. In this report, the
response of Pisum sativum guard cells to pyrabactin during
stomatal closure was studied and the effects with ABA were
compared. The effect of ABA on stomatal closure was
examined in detail as well as changes in the signalling
components, including pH, ROS, and NO. The inﬂuence of
pyrabactin on stomata was then examined in the absence/
presence of ABA and vice versa. Attempts were made to
determine the apparent KD for pyrabactin and ABA.
Materials and methods
Chemicals
Pyrabactin and apyrabactin were from Sigma-Aldrich and Chem-
bridge Corporation (San Diego, CA), respectively. DAF-2DA was
from Calbiochem (Rockland, MA). BCECF-AM was from
Invitrogen (Molecular Probes). The remaining chemicals were
from Sigma-Aldrich. The stock solutions of ABA and fusicoccin
were prepared in ethanol and methanol, respectively. The stocks of
pyrabactin, apyrabactin, ﬂuorescent probes, and DPI were in
DMSO and all the remaining chemicals were in milli Q water.
Stock solutions were prepared in such a way that the ﬁnal
concentration of solvent was <0.2% in the ﬁnal medium.
Plant materials and growth conditions
Plants of pea (Pisum sativum L., cv. Arkel) were raised from seeds,
procured from Pocha Seeds, Pune, India. The plants were grown
outdoors under a natural photoperiod of approximately 12 h and
an average temperature of 30/20  C day/night. The second pair of
fully unfolded leaves was picked at about 09.00 h from 9–15-d-old
plants for subsequent use.
Stomatal closure in epidermal strips
The abaxial epidermis was peeled from the leaves and cut into
pieces of c. 0.4 cm
2. Twenty-ﬁve epidermal strips were transferred
to 3 cm diameter Petri dishes containing 3 ml of opening medium
(10 mM MES-KOH, pH 7.0, and 50 mM KCl). The epidermal
strips were exposed to a bank of tungsten lamps, whose light was
ﬁltered through water jacket white light of 200–-250 lmol m
2 s
1,
for 150 min, to get maximum stomatal opening. Photon ﬂux was
measured with a Li-Cor quantum sensor (Li-Cor Instruments Ltd,
Lincoln, NE, USA). The temperature was maintained at 2561  C.
After 150 min of illumination, three epidermal strips were trans-
ferred to each of 24 well plates, containing medium and the
required concentrations of ABA, pyrabactin or test compounds
(inhibitors or scavengers). Illumination was continued for the next
120 min, before measuring stomatal apertures. When used
together, the test compounds were added 15 min prior to the
addition of ABA or pyrabactin.
The width of the stomatal apertures was measured under
a research microscope with the help of a precalibrated ocular
micrometer. 10–-15 apertures were monitored at random in each of
three different epidermal strips, from each treatment. The experi-
ments were repeated on at least three different days, making each
measurement of stomatal aperture an average of a minimum of 90
stomata.
Fluorescent probes to monitor ROS, NO or cytoplasmic pH
changes
Changes in ROS, NO or cytoplasmic pH levels in guard cells were
monitored by using respective ﬂuorescent probes, 2#,7#-dichloro-
ﬂuorescien diacetate (H2DCF-DA); 4, 5-diaminoﬂuorescein
diacetate (DAF-2DA); or 2#,7#-bis-(2-carboxyethyl)-5-(and-6)-
carboxyﬂuorescein), acetoxymethyl ester (BCECF-AM) (Murata
et al., 2001; Neill et al., 2002; Gonugunta et al., 2008). Epidermal
peels were mounted on a microscope slide with medical adhesive
Telesis V (Premiere Products Inc., Pacaima, California, USA).
Stomata were allowed to open by incubating epidermal tissues
under 200–250 lmol m
2 s
1 white light for 150 min, in a medium
of 10 mM MES-KOH, pH 7.0, and 50 mM KCl. After 150 min,
the epidermal tissues were loaded with 30 lMH 2DCF-DA, 10 lM
DAF-2DA or 5 lM BCECF-AM (30 min in dark), respectively, at
2561  C. The strips were rinsed with incubation buffer, to wash
off excessive ﬂuorophore. For studying time-course changes in
ROS/NO/pH levels, the epidermal tissues were treated with 20 lM
ABA or 20 lM pyrabactin, at zero-time and changes in
ﬂuorescence levels were measured at 3 min intervals. In the control
sets, an equal and appropriate volume of ethanol or DMSO was
added. Modulators were added 10 min prior to the addition of
20 lM ABA or 20 lM pyrabactin. The data are representative of
the averages 6SE of three independent experiments, with measure-
ments on a minimum of 60 individual stomata.
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an inverted ﬂuorescence microscope (Optiphot-2, Nikon, Japan)
ﬁtted with a monochrome high-resolution digital cooled CD
camera (Cool snap FX) that enabled the quick capture of images,
for further analysis later on. The captured images and the relative
ﬂuorescence emission of guard cells were analysed by using NIH
Image for Windows (Murata et al., 2001; Suhita et al., 2004).
Fluorescence intensity was measured in pixels in a scale of
0 (darkest) to 250 (brightest). The ﬂuorescence intensity in the
guard cells, without ABA, pyrabactin or any effectors (at the
beginning of the experiment), was taken as 100% (Suhita et al.,
2004; Gonugunta et al., 2008). In some of the experiments (as
indicated in the ﬁgure legends), a confocal microscope (TCSSP-2,
AOBS 4 channel UV and visible; Leica, Heidelberg, Germany) was
used to observe the changes in ﬂuorescence indicating ROS, NO or
cytoplasmic pH.
Results
Pyrabactin induced stomatal closure and changes in
ROS, NO, and cytoplasmic pH levels in guard cells
ABA or its analogue pyrabactin caused stomatal closure in
a concentration-dependent manner. The concentrations of
ABA or pyrabactin, required for maximal stomatal closure,
were quite similar (Fig. 1a, b). By contrast, apyrabactin, an
inactive analogue of ABA, did not have any signiﬁcant
effect on stomata (Fig. 1c). The presence of fusicoccin (FC,
a fungal toxin) prevented the stomatal closure caused by
either ABA or pyrabactin (Fig. 2).
Pyrabactin increased ROS, NO, and cytoplasmic pH
levels in guard cells within a few minutes after treatment,
when compared with their respective controls (Fig. 3).
Apyrabactin, an inactive analogue of ABA, did not cause
any noticeable changes in ROS/NO/pH of guard cells
(Fig. 3d, h, l). The initial rise of H2DCF-DA ﬂuorescence
(indicating ROS levels) was seen at 6 min after treatment
and ﬂuorescence peaked between 18–24 min (Fig. 4a).
Similarly, NO-speciﬁc DAF-2DA ﬂuorescence (indicating
NO) showed an initial rise at 9 min after treatment and
ﬂuorescence peaked after 18 min of treatment (Fig. 4b). The
BCECF-AM ﬂuorescence (reﬂecting the pH) initially
increased within 3 min and peaked after 24 min (Fig. 4c).
A similar pattern of changes were observed with ABA.
Modulators of ROS/NO/pH can relieve pyrabactin-
induced stomatal closure and dampen the rise in ROS,
NO or pH levels of guard cells
ROS modulators: DPI (NADPH oxidase inhibitor) or
catalase (H2O2 scavenging enzyme), partially relieved sto-
matal closure by ABA or pyrabactin. Similarly, stomatal
closure by ABA or pyrabactin was compromised in the
presence of either cPTIO (NO scavenger), or L-NAME
(nitric oxide synthase inhibitor) or tungstate (nitrate re-
ductase inhibitor). Butyrate (a weak acid), relieved stomatal
closure induced by ABA or pyrabactin (Fig. 5).
Catalase completely relieved the increase in H2DCF-DA
ﬂuorescence by pyrabactin or ABA, while DPI had a partial
effect, conforming the increase in ﬂuorescence due to ROS
(Fig. 6). DAF-2DA ﬂuorescence increase by ABA or
pyrabactin was abolished by cPTIO (NO scavenger).
Similarly, L-NAME or tungstate (inhibitors of NO synthase
or nitrate reductase) restricted the DAF-2DA ﬂuorescence
increase by ABA or pyrabactin. Butyrate restricted the rise
in BCECF-AM ﬂuorescence by ABA or pyrabactin.
Pyrabactin competes with ABA during stomatal closure
Experiments using varied concentrations of pyrabactin
(0–100 lM), in the absence or presence of 5 lM ABA and
vice-versa (varied concentrations of ABA in the absence or
presence of 5 lM pyrabactin), revealed that the effects of
ABA and pyrabactin were additive (Fig. 7). Kinetic analyses
of these data indicated that the apparent IC50 of pyrabactin
or ABA did not change much in the presence of ABA or
pyrabactin (Fig. 7a, b). By contrast, the double reciprocal
Fig. 1. Effect of ABA, pyrabactin or apyrabactin concentrations on stomata in abaxial epidermis of Pisum sativum. ABA or pyrabactin
caused marked stomatal closure in a similar pattern, while apyrabactin did not have any signiﬁcant effect. The data are averages of three
independent experiments 6SE.
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ABA or pyrabactin (0.5–5 lM) in the absence or presence
of 5 lM pyrabactin or ABA demonstrated that the KD of
ABA increased by almost 4-fold in the presence of
pyrabactin and the KD of pyrabactin increased by nearly
3-fold in the presence of ABA (Fig. 7c, d).
Discussion
Pyrabactin, a synthetic ABA analogue, is considered to be
a potential tool in future agriculture. Initially identiﬁed as
a seed germination inhibitor, pyrabactin led the way for the
identiﬁcation, puriﬁcation, and characterization of ABA
receptors. Most of the earlier experiments with pyrabactin
were done on either germinating seeds or in vitro reconsti-
tuted systems. Our results present an unequivocal and direct
demonstration that pyrabactin is as powerful as ABA in
promoting stomatal closure in abaxial epidermis.
Pyrabactin is as powerful as ABA in inducing stomatal
closure
Pyrabactin caused a marked reduction in stomatal aperture.
The effective concentrations, as well as the effect of
pyrabactin on stomatal closure, were quite similar to ABA
(Fig. 1). In contrast, apyrabactin did not induce closure of
Fig. 2. Effect of fungal toxin, fusicoccin (FC), on stomatal closure
caused by ABA or pyrabactin. Fusicoccin completely relieved
stomatal closure by ABA or pyrabactin. The data are means of
three experiments 6SE.
Fig. 3. Representative confocal images showing the changes in ROS, NO, and cytoplasmic pH changes in Pisum sativum guard cells in
the presence or absence of ABA, pyrabactin or apyrabactin. (a–d) Changes in ROS levels as indicated by H2DCF-DA ﬂuorescence. (e–h)
Changes in NO levels as indicated by DAF2-DA ﬂuorescence. (i–l) Changes in cytoplasmic pH levels as indicated by BCECF-AM
ﬂuorescence. ABA or pyrabactin increased the levels of ROS, NO, and cytoplasmic pH, compared to respective controls.
1352 | Puli and RaghavendraFig. 5. The effect of ROS, NO or pH modulators on stomatal closure caused by ABA or pyrabactin. The decrease in stomatal aperture by
ABA or pyrabactin was relieved by ROS modulators, catalase or DPI (a), NO modulators cPTIO and L-NAME or tungstate (b), and pH
modulator, butyrate (c). The data are means 6SE of three independent experiments, each representing a minimum of 90 individual stomata.
Fig. 6. Effect of ROS, NO or pH modulators on H2DCF-DA, DAF2-DA, or BCECF-AM ﬂuorescence levels respectively. Changes in
ﬂuorescence levels were monitored by using an inverted ﬂuorescence microscope. (a) ROS modulators, catalase or DPI, prevented ABA or
pyrabactin-induced increase of H2DCF-DA ﬂuorescence. (b) NO modulators, cPTIO and L-NAME or tungstate, prevented ABA- or
pyrabactin-induced increase of DAF2-DA ﬂuorescence. (c) Butyrate, a pH modulator, restricted the ABA- or pyrabactin-induced increase in
BCECF-AM ﬂuorescence. The data are averages 6SE of three independent experiments, each with a minimum of 60 individual stomata.
Fig. 4. Changes with time in ﬂuorescence of guard cells, loaded with ﬂuorescent probes speciﬁc for ROS, NO or pH. The ﬂuorescence
was monitored at different times after exposure to pyrabactin or ABA, using an inverted ﬂuorescence microscope. The details are
described in the Materials and methods. ABA or pyrabactin increased with time in the ﬂuorescence intensities of H2DCF-DA, DAF2-DA,
and BCECF-AM reﬂecting the rise in ROS, NO, and pH of guard cells. The effects of pyrabactin and ABA were quite similar. The data are
averages 6SE of three independent experiments, each representing a minimum of 60 individual stomata.
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during stomatal closure. Park et al. (2009) have reported
that pyrabactin caused the inhibition of seed germination
like ABA, and facilitated the binding of PP2C with PYR1
during seed germination, while apyrabactin did not. These
observations demonstrate that pyrabactin is an agonist of
ABA, while apyrabactin is not an agonist. Several effects of
ABA, such as the inhibition of seed germination or the
promotion of stomatal closure are reversed by FC (She
et al.,2 0 1 0 ; Zeng et al., 2010). The stomatal closure caused
by pyrabactin was also reversed completely by FC (Fig. 2),
reconﬁrming our observations that pyrabactin is a strong
mimic of ABA, in its effect on stomata.
Signalling components during pyrabactin-induced
stomatal closure
The signalling components involved during ABA-induced
stomatal closure have been extensively studied. After the
initial recognition of ABA signal, through the ABA-PYR/
PYL/RCAR-PP2C complex, the ABA-responsive kinases
are activated. Subsequently, the guard cell pH becomes
alkaline, the membrane-bound NADPH oxidase becomes
active, the ROS levels are elevated, followed by a rise in NO
Fig. 7. Additive effect of ABA and pyrabactin during stomatal closure. (a) The apparent IC50 of ABA changed from 4.26 lM to 4.88 lMi n
the presence of 5 lM pyrabactin, when the change in stomatal closure was plotted as a function of concentration of ABA. (b) The
apparent IC50 of pyrabactin changed from 4.47 lM to 5.05 lM in the presence of 5 lM ABA, when the change in stomatal closure was
plotted as a function of concentration of pyrabactin. (c) The double reciprocal plot showing the increase of the apparent KD of ABA,
almost 4-fold, from 1.08 lM to 3.82 lM in the presence of 5 lM pyrabactin. (d) The double reciprocal plot demonstrated that the
apparent KD of pyrabactin increased by almost 3-fold from 1.17 lM to 3.05 lM in the presence of 5 lM ABA. The marked increase in KD
of ABA/pyrabactin in the presence of pyrabactin/ABA suggested their competition at or near their binding site during stomatal closure.
The data are the average means of three independent experiments.
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et al., 2008; Kim et al., 2010). On exposure to pyrabactin
too, there were marked increases in pH, ROS, and NO
levels (Fig. 3). Again, apyrabactin, an inactive analogue, did
not cause any signiﬁcant changes in the signalling compo-
nents of guard cells (Fig. 3). It was therefore concluded that
pyrabactin is an active analogue of ABA, in relation to its
inﬂuence on stomatal function and signal transduction in
guard cells. The present study illustrated that pyrabactin
could successfully induce stomatal closure and generate
small intracellular components, ROS, and NO during
stomatal closure besides increasing the cytoplasmic pH.
However, the exact mechanism of the induction of these
signalling events is not yet known. It is quite possible that
pyrabactin induces ROS and NO production in guard cells
by the mediation of PYR/PYL/RCARs, PP2Cs, and OST1/
SnRK2.6.
The kinetics of the rise in pH/ROS/NO as indicated by
the respective ﬂuorophores (Fig. 4) suggested that there was
marked similarity in the sequence of changes due to
pyrabactin or ABA. The ability of DPI and L-NAME to
dampen the pyrabactin-induced rise in ROS/NO indicates
that NADPH oxidase and putative NOS play an important
role during pyrabactin effects. That the action of either
pyrabactin or ABA required the alkalinization of guard
cells was evident by the ability of butyrate to prevent the
rise in pH as well as closure (Figs 5, 6). The effect of
pyrabactin on stomatal closure and its dependence on rise
in pH/ROS/NO of guard cells strikes a strong similarity
with the action of ABA as well as methyl jasmonate (Suhita
et al., 2004; Gonugunta et al., 2008, 2009).
ABA and pyrabactin compete during stomatal closure
Further experiments on stomatal closure in response to
varying concentrations of pyrabactin, in the presence of
ﬁxed concentration of ABA and vice versa, revealed in-
teresting information on the apparent IC50 and KD values of
pyrabactin in relation to ABA (Fig. 7). The method
followed here is similar to that used for examining the
ethylene effects on bud and ﬂower drop of Begonia in the
presence of the gaseous ethylene-binding inhibitor, silver
thiosulphate (Serek et al., 1994). The apparent IC50 for
pyrabactin did not change much in the presence of ABA or
vice versa (Fig. 7a, b). By contrast, the KD of pyrabactin or
ABA (about 4–5 mM) was elevated in the presence of ABA
or pyrabactin (Fig. 7c, d). These results suggested that
pyrabactin was competing with ABA during the induction
of stomatal closure, either at the active site or very close to
the active site on ABA receptors. These values of IC50 or
KD values for pyrabactin or ABA (4–5 lM) appear high
compared with the IC50 values reported for ABA (60–125
lM) during interaction with PP2C in vivo using a reconsti-
tuted system (Ma et al., 2009; Park et al., 2009). However, it
has already been noted that the IC50 values of ABA to
interact in vivo with PP2C (60 nM) can vary with that for
suppressing root growth (3 lM), as observed by Ma et al.
(2009). Similarly, IC50 values of 2–4 lM were reported for
pyrabactin during the inhibition of seed germination and
hypocotyl elongation (Park et al., 2009).
The limitations of our experiments are acknowledged.
For example, only the amount of pyrabactin or ABA in the
external medium is known. The actual concentrations of
pyrabactin or ABA within the cells (at the ABA receptor
level) would be much less. Further, the rate of movement of
pyrabactin or ABA across the guard cell could also vary.
These factors can explain the differences in the observed KD
for pyrabactin/ABA in our experiments (done in vivo) and
the values obtained during reconstitution attempts (in vitro)
by Park et al. (2009) and Hao et al. (2010).I nArabidopsis
seed germination assays, the pyrabactin concentration
(100 lM) required to get an effect similar to ABA (10 lM)
was almost 10 times higher (Park et al., 2009; Melcher et al.,
2010b). However, our major point, that pyrabactin and
ABA are competiting with each other, seems to be certain.
Concluding remarks
The ability of pyrabactin, an analogue of ABA, to induce
stomatal closure in Pisum sativum leaf abaxial epidermis
was as powerful as ABA. This observation opens up an ex-
citing possibility of using pyrabactin as an anti-transpirant.
However, it is necessary to explore the possibility of syn-
thesizing pyrabactin and/or analogues at an affordable price
for suitable application in agriculture. Since the pattern of
signalling components in response to pyrabactin and the
reversal of pyrabactin effects by modulators was quite
similar to that of ABA, it is suggested that pyrabactin and
similar synthetic compounds could be quite useful in
studying the signal transduction mechanisms in guard cells
as well as in other plant tissues. Being quite similar to ABA
in its mode of action, pyrabactin offers a promising
potential for use in improving the plant adaptation to
drought or other stress conditions.
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